Australia's most trusted
source of pharma news
Friday, 14 November 2025
Posted 14 November 2025 AM
Arrotex is stepping in to fill the hole created by the discontinuation of a hypertension drug from next month.
ARX-Telmisartan/Amlodipine was listed on the PBS this month, subsidised for patients whose blood pressure is not adequately controlled with monotherapy. It's a generic version of Boehringer Ingelheim's Twynsta, which the pharma is discontinuing in Australia, as well as its own generic Pritor/Amlodipine.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.